Georges Dagher, senior investigator at Inserm (Paris, France) accomplished most of his career in pathophysiological and clinical research at Necker Hospital (1979-1984), College de France (1985-1993) and Faculty of medicine Broussais-Hotel Dieu (1994-2004). He joined the Physiological Laboratory (Cambridge, UK) for a post doc fellowhip (1983-85) and was a special guest to Physiological laboratory (Harvard Medical School, Boston, US, 1982, 1984). Georges Dagher published 90 papers in international peer-reviewed journals on hypertension, arterial hypertrophy, obesity and lipid metabolism, manic depression, renal physiology and transmembrane ion transport.
He is currently the Director of BIOBANQUES  infrastructure (Inserm US 13), a French infrastructure that regroups 74 biobanks. He was the coordinator of Biological resources centres at Inserm (2006), the director of clinical research infrastructures at Inserm (2006-2009) and the deputy director of the department of clinical research at the Public Health Institute, Inserm, France (2009-2011). Since 2005, He is involved in organizing and evaluating several clinical research infrastructures, biobanks and translational research calls.
 He participated actively to the preparatory phase of the pan-European biobanking and biomolecular research infrastructure (BBMRI). In this infrastructure he is a leading figure of the coordination committee and leader of a Work Package on funding and financing. He coordinated the report on socio-economic impact of BBMRI, drafted by experts from Technopolis, Bureau d’Economie Théorique et Appliquée (BETA, Strasbourg University) and Fraunhofer institute for Biomedical Engineering (IBMT). He is also a member of coordination team of BIOSHARE and BBMRI- LS within the 7th EU framework program. He contributed to the OECD best practice guidelines for biological resource centres and the OECD guidelines on human biobanks and genetic databases. He participated in the elaboration of the french norm for biobanks NF S96-900 norm and member of the AFNOR normalisation committee.
He is a delegate of several French institutions to European and international committees or meetings (OECD, ESF, ERA, ALLEA, EASAC…) and a number of expert committees focusing on the issues related to biobanks within Europe and internationally.He is an expert to the Austrian Federal ministry of science and research (BMWF) He was also a member of the Inserm ethics committee and the Institutional Review Board (IRB).